Dominique Stoppat-Lyonnet

30PUBLICATIONS
354CO-AUTHORS
Haematological tumoursCancer geneticsMedical infection agents (incl. prions)Gene expression (incl. microarray and other genome-wide approaches)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Mar 25, 2026
Predisposition to ALL and Solid Tumors Rather Than Bone Marrow Failure in FANCM-Associated Fanconi Anemia.

Francesco Pegoraro, Lise Larcher, Rathana Kim

|Dec 10, 2025
A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription.

Anna Minello, Jesus Gomez-Escudero, Sreerama Chaitanya Sridhara

|Oct 03, 2025
Myeloid neoplasms risks for germline DDX41 pathogenic variants carriers.

Marie-Charlotte Villy, Youenn Drouet, Lise Larcher

|Jun 10, 2025
Body Mass Index, IGF1-Related Polymorphisms, and Risk of Familial Breast Cancer in Women with No BRCA1 or BRCA2 Pathogenic Variant.

Barbara Fritsch-Humblet, Yue Jiao, Séverine Eon-Marchais

|Mar 12, 2025
Breast tumors from ATM pathogenic variant carriers display a specific genome-wide DNA methylation profile.

Nicolas M Viart, Anne-Laure Renault, Séverine Eon-Marchais

|Feb 24, 2025
Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition.

Peter N Fiorica, Lisa Golmard, Jung Kim

Pageof 5